$ACRE
Ares Commercial Real Estate Corp Stock $acre

$acre Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000162828021002412 Filed on February 18, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2018 Q4
Revenue	$32.71M	$13.49M	$14.53M
YoY Change	142.44%	-7.11%	33.6%
Cost Of Revenue	$14.31M	$17.42M	$18.47M
YoY Change	-17.85%	-5.68%	16.16%
Gross Profit	$18.40M	$19.21M	$12.41M
YoY Change	-4.22%	54.79%	33.15%
Gross Profit Margin	56.25%	142.38%	85.44%
Selling, General & Admin	$5.640M	$9.140M	$2.350M
YoY Change	-38.29%	288.94%	0.43%
% of Gross Profit	30.65%	47.58%	18.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$200.0K	$300.0K	$0.00
YoY Change	-33.33%
% of Gross Profit	1.09%	1.56%	0.0%
Operating Expenses	$3.990M	$9.360M	$2.350M
YoY Change	-57.37%	298.3%	0.43%
Operating Profit	$14.41M	$9.850M	$10.06M
YoY Change	46.29%	-2.09%	44.13%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$14.41M	$9.840M	$10.06M
YoY Change	46.44%	-2.19%	62.0%
Income Tax	$0.00	$180.0K	$40.00K
% Of Pretax Income	0.0%	1.83%	0.4%
Net Earnings	$14.41M	$9.660M	$10.02M
YoY Change	49.14%	-3.57%	62.02%
Net Earnings / Revenue	44.04%	71.6%	68.97%
Basic Earnings Per Share
Diluted Earnings Per Share	$429.3K	$334.6K	$349.0K
COMMON SHARES
Basic Shares Outstanding	33.44M shares	28.87M shares	28.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$74.80M	$5.300M	$11.10M
YoY Change	1311.32%	-52.25%	-60.78%
Cash & Equivalents	$74.78M	$5.256M	$11.09M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$74.80M	$5.300M	$11.10M
YoY Change	1311.32%	-52.25%	-60.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.30M	$37.90M
YoY Change	-1.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$1.683B	$1.525B
YoY Change		10.34%	-11.67%
Other Assets	$0.00	$400.0K	$400.0K
YoY Change	-100.0%	0.0%	0.0%
Total Long-Term Assets	$1.855B	$1.779B	$1.592B
YoY Change	4.26%	11.72%	-8.59%
TOTAL ASSETS
Total Short-Term Assets	$74.80M	$5.300M	$11.10M
Total Long-Term Assets	$1.855B	$1.779B	$1.592B
Total Assets	$1.929B	$1.784B	$1.603B
YoY Change	8.15%	11.28%	-9.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.30M	$12.30M	$12.10M
YoY Change	16.26%	1.65%	16.35%
LONG-TERM LIABILITIES
Long-Term Debt	$1.431B	$1.336B	$1.157B
YoY Change	7.15%	15.43%	-13.44%
Other Long-Term Liabilities	$11.20M	$9.900M	$8.600M
YoY Change	13.13%	15.12%	120.51%
Total Long-Term Liabilities	$1.442B	$1.346B	$1.166B
YoY Change	7.19%	15.42%	-13.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.30M	$12.30M	$12.10M
Total Long-Term Liabilities	$1.442B	$1.346B	$1.166B
Total Liabilities	$1.456B	$1.358B	$1.178B
YoY Change	7.27%	15.29%	-12.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.12M	$2.437M	$3.565M
YoY Change	-1130.65%	-31.64%	-303.71%
Common Stock	$498.1M	$423.9M	$422.0M
YoY Change	17.51%	0.45%	0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$473.0M	$426.3M	$425.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.929B	$1.784B	$1.603B
YoY Change	8.15%	11.28%	-9.43%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2018 Q4
OPERATING ACTIVITIES
Net Income	$14.41M	$9.660M	$10.02M
YoY Change	49.14%	-3.57%	62.02%
Depreciation, Depletion And Amortization	$200.0K	$300.0K	$0.00
YoY Change	-33.33%
Cash From Operating Activities	$9.100M	$7.600M	$10.90M
YoY Change	19.74%	-30.28%	47.3%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$100.0K	$0.00
YoY Change	0.0%
Acquisitions
YoY Change
Other Investing Activities	$23.40M	-$106.5M	$139.3M
YoY Change	-121.97%	-176.45%	-176.79%
Cash From Investing Activities	$23.40M	-$106.6M	$139.3M
YoY Change	-121.95%	-176.53%	-176.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-39.00M	98.30M	-144.2M
YoY Change	-139.67%	-168.17%	-182.83%
NET CHANGE
Cash From Operating Activities	9.100M	7.600M	10.90M
Cash From Investing Activities	23.40M	-106.6M	139.3M
Cash From Financing Activities	-39.00M	98.30M	-144.2M
Net Change In Cash	-6.500M	-700.0K	6.000M
YoY Change	828.57%	-111.67%	5900.0%
FREE CASH FLOW
Cash From Operating Activities	$9.100M	$7.600M	$10.90M
Capital Expenditures	-$100.0K	-$100.0K	$0.00
Free Cash Flow	$9.200M	$7.700M	$10.90M
YoY Change	19.48%	-29.36%	47.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	1815219000	USD
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001529377
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	29100000	USD
CY2020	acre	Percentage Of Loans Held For Investment Having Libor Floors PercentageOfLoansHeldForInvestmentHavingLIBORFloors	0.953
CY2020	acre	Loans Receivable Description Of Variable Rate Basis Weighted Average Floor LoansReceivableDescriptionOfVariableRateBasisWeightedAverageFloor	0.0173
CY2020Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2400000	USD
CY2020Q4	us-gaap	Professional Fees ProfessionalFees	400000	USD
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-35517
CY2020	dei	Entity Registrant Name EntityRegistrantName	ARES COMMERCIAL REAL ESTATE CORPORATION
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-3148087
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	245 Park Avenue
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	42nd Floor
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10167
CY2020	dei	City Area Code CityAreaCode	212
CY2020	dei	Local Phone Number LocalPhoneNumber	750-7300
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2020	dei	Trading Symbol TradingSymbol	ACRE
CY2020	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	274443403	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33477841	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74776000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5256000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	379000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1815219000	USD
CY2019Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1682498000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	23604000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	1791615000	USD
CY2019Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest Net MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterestNet	1682498000	USD
CY2020Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	37283000	USD
CY2019Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	37901000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	25823000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	58100000	USD
CY2020Q4	us-gaap	Assets Assets	1929497000	USD
CY2019Q4	us-gaap	Assets Assets	1784134000	USD
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	755552000	USD
CY2019Q4	us-gaap	Line Of Credit LineOfCredit	728589000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	61837000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	54708000	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	110000000	USD
CY2019Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	109149000	USD
CY2020Q4	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	443871000	USD
CY2019Q4	acre	Variable Interest Entity Collateralized Loan Obligation Securities Long Term Debt VariableInterestEntityCollateralizedLoanObligationSecuritiesLongTermDebt	443177000	USD
CY2020Q4	us-gaap	Secured Debt SecuredDebt	59790000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	0	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3150000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	2761000	USD
CY2020Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11124000	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9546000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	11158000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	9865000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1456482000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1357795000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33442332	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33442332	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28865610	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28865610	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	329000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	283000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	497803000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	423619000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25117000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2437000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	473015000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	426339000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1929497000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1784134000	USD
CY2020	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	121052000	USD
CY2019	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	114784000	USD
CY2018	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	118284000	USD
CY2020	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	51949000	USD
CY2019	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	62583000	USD
CY2018	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	63002000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	69103000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	52201000	USD
CY2018	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	55282000	USD
CY2020	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	13593000	USD
CY2019	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	25058000	USD
CY2018	acre	Operating Revenuefrom Real Estate Owned OperatingRevenuefromRealEstateOwned	0	USD
CY2020	us-gaap	Revenues Revenues	82696000	USD
CY2019	us-gaap	Revenues Revenues	77259000	USD
CY2018	us-gaap	Revenues Revenues	55282000	USD
CY2020	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	8159000	USD
CY2019	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	7363000	USD
CY2018	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	7418000	USD
CY2020	us-gaap	Professional Fees ProfessionalFees	2640000	USD
CY2019	us-gaap	Professional Fees ProfessionalFees	2194000	USD
CY2018	us-gaap	Professional Fees ProfessionalFees	1945000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3732000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4188000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3307000	USD
CY2020	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	3653000	USD
CY2019	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	3026000	USD
CY2018	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	3570000	USD
CY2020	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	18127000	USD
CY2019	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	22982000	USD
CY2018	acre	Operating Expenses From Real Estate Owned OperatingExpensesFromRealEstateOwned	0	USD
CY2020	us-gaap	Noninterest Expense NoninterestExpense	36311000	USD
CY2019	us-gaap	Noninterest Expense NoninterestExpense	39753000	USD
CY2018	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
CY2020	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	-4008000	USD
CY2018	us-gaap	Noninterest Expense NoninterestExpense	16240000	USD
CY2020	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	20185000	USD
CY2019	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
CY2019	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	0	USD
CY2018	us-gaap	Held To Maturity Securities Sold Security Realized Gain Loss HeldToMaturitySecuritiesSoldSecurityRealizedGainLoss	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	22192000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37506000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	39042000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	352000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	515000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	446000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	21840000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	36991000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	38596000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.66
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.29
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.35
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.66
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.28
CY2018	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.35
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32977462	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28609282	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28529439	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33196508	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28846641	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28656660	shares
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419170000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1102000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	38596000	USD
CY2018	us-gaap	Dividends Cash DividendsCash	33281000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	36991000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	425587000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1880000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	36991000	USD
CY2019	us-gaap	Dividends Cash DividendsCash	38119000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	426339000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73232000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	341000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1339000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	21840000	USD
CY2020	us-gaap	Dividends Cash DividendsCash	44343000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	473015000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	21840000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	38596000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6434000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6569000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5720000	USD
CY2020	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	7430000	USD
CY2019	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	7013000	USD
CY2018	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	6949000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1339000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1880000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1102000	USD
CY2020	us-gaap	Depreciation Depreciation	892000	USD
CY2019	us-gaap	Depreciation Depreciation	667000	USD
CY2018	us-gaap	Depreciation Depreciation	0	USD
CY2020	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	20185000	USD
CY2019	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2018	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	-4008000	USD
CY2019	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	0	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15344000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6435000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-198000	USD
CY2020	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	389000	USD
CY2019	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-402000	USD
CY2018	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	535000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-551000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	195000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	16000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31762000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32452000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39218000	USD
CY2020	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	524166000	USD
CY2019	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	673160000	USD
CY2018	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	543077000	USD
CY2020	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	341450000	USD
CY2019	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	492884000	USD
CY2018	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	695183000	USD
CY2020	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	96597000	USD
CY2019	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	0	USD
CY2018	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	0	USD
CY2020	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	4526000	USD
CY2019	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	7536000	USD
CY2018	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	5818000	USD
CY2020	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	274000	USD
CY2019	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	1686000	USD
CY2018	us-gaap	Payments To Acquire Real Estate Held For Investment PaymentsToAcquireRealEstateHeldForInvestment	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81867000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174426000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	157924000	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	473493000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	793801000	USD
CY2018	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	642241000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	446530000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	843186000	USD
CY2018	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	822227000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6967000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	56155000	USD
CY2018	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	60215000	USD
CY2019	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2018	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2020	acre	Payments Of Secured Funding Costs PaymentsOfSecuredFundingCosts	5065000	USD
CY2019	acre	Payments Of Secured Funding Costs PaymentsOfSecuredFundingCosts	5731000	USD
CY2018	acre	Payments Of Secured Funding Costs PaymentsOfSecuredFundingCosts	2322000	USD
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	172673000	USD
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	42765000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	37487000	USD
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	32088000	USD
CY2020	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	73232000	USD
CY2019	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	0	USD
CY2018	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	0	USD
CY2020	acre	Payments For Offering Costs On Public Offering PaymentsForOfferingCostsOnPublicOffering	301000	USD
CY2019	acre	Payments For Offering Costs On Public Offering PaymentsForOfferingCostsOnPublicOffering	84000	USD
CY2018	acre	Payments For Offering Costs On Public Offering PaymentsForOfferingCostsOnPublicOffering	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	119246000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136141000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-214396000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69141000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5833000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17254000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5635000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11468000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	46137000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5635000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11468000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28722000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74776000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	54595000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	56719000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	399000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	668000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	360000	USD
CY2020	acre	Dividend Declared Not Yet Paid DividendDeclaredNotYetPaid	11124000	USD
CY2019	acre	Dividend Declared Not Yet Paid DividendDeclaredNotYetPaid	9546000	USD
CY2018	acre	Dividend Declared Not Yet Paid DividendDeclaredNotYetPaid	8914000	USD
CY2020	us-gaap	Notes Issued1 NotesIssued1	6410000	USD
CY2019	us-gaap	Notes Issued1 NotesIssued1	41104000	USD
CY2018	us-gaap	Notes Issued1 NotesIssued1	51582000	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. As of the filing date of this Annual Report, there is a continued outbreak of the novel Coronavirus pandemic (“COVID-19”), for which the World Health Organization has declared a global pandemic, the United States has declared a national emergency and every state in the United States is under a federal disaster declaration. Many states, including those in which the Company and its borrowers operate, have issued orders requiring the closure of, or certain restrictions on the operation of, non-essential businesses and/or requiring residents to stay at home. The COVID-19 pandemic and preventative measures taken to contain or mitigate its spread have caused, and are continuing to cause, business shutdowns or the re-introduction of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. While several countries, as well as certain states in the United States, have relaxed the public health restrictions with a view to partially or fully reopen their economies, recurring COVID-19 outbreaks have led to the re-introduction of such restrictions in certain states in the United States and globally and could continue to lead to the re-introduction of such restrictions elsewhere.</span></div>Additionally, in December 2020, the U.S. Food and Drug Administration authorized certain vaccines for emergency use. However, it remains unclear how quickly the vaccines will be distributed nationwide and globally or when “herd immunity” will be achieved and the restrictions that were imposed to slow the spread of the virus will be lifted entirely. The delay in distributing the vaccines could lead people to continue to self-isolate and not participate in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and we anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States. The Company believes the estimates and assumptions underlying its consolidated financial statements are reasonable and supportable based on the information available as of December 31, 2020, however, uncertainty over the ultimate impact the COVID-19 pandemic will have on the global economy and the Company’s business, makes any estimates and assumptions as of December 31, 2020 inherently less certain than they would be absent the current and potential impacts of the COVID-19 pandemic. Actual results could differ from those estimates.
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74776000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74776000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5256000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11089000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	379000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	379000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5635000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11468000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and restricted cash, loans held for investment and interest receivable. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation insured limit. The Company has exposure to credit risk on its loans held for investment. The Company and the Company’s Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non‑recourse financing, when and where available and appropriate.</span></div>
CY2020	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	51949000	USD
CY2020	acre	Mortgage Loans On Real Estate Number Of Loans Repaid Or Sold Since Inception MortgageLoansOnRealEstateNumberOfLoansRepaidOrSoldSinceInception	98	loan
CY2019	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	62583000	USD
CY2018	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	63002000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	srt	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	50	loan
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount MortgageLoansOnRealEstateTotalCommitmentAmount	2100000000	USD
CY2020Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Excluding Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountExcludingNoncontrollingInterest	1800000000	USD
CY2020	acre	Payments To Acquire Loans Held For Investment Including Non Cash Upsize And Excluding Capitalized Funding PaymentsToAcquireLoansHeldForInvestmentIncludingNonCashUpsizeAndExcludingCapitalizedFunding	538300000	USD
CY2020	srt	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	304000000.0	USD
CY2020	acre	Mortgage Loans On Real Estate Number Of Loans Repaid MortgageLoansOnRealEstateNumberOfLoansRepaid	3	loan
CY2020Q4	us-gaap	Principal Amount Outstanding On Loans Held For Sale Or Securitization PrincipalAmountOutstandingOnLoansHeldForSaleOrSecuritization	101000000.0	USD
CY2020	acre	Percentage Of Loans Held For Investment Having Libor Floors PercentageOfLoansHeldForInvestmentHavingLIBORFloors	0.953
CY2020	acre	Loans Receivable Description Of Variable Rate Basis Weighted Average Floor LoansReceivableDescriptionOfVariableRateBasisWeightedAverageFloor	0.0173
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1815219000	USD
CY2020Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1826241000	USD
CY2020	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Including Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldIncludingNonaccrualLoans	0.063
CY2020	acre	Mortgage Loanson Real Estate Unleveraged Effective Yield Excluding Nonaccrual Loans MortgageLoansonRealEstateUnleveragedEffectiveYieldExcludingNonaccrualLoans	0.066
CY2020	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y2M12D
CY2019Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1682498000	USD
CY2019Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1692894000	USD
CY2019	srt	Mortgage Loans On Real Estate Interest Rate MortgageLoansOnRealEstateInterestRate	0.068
CY2019	acre	Mortgage Loans On Real Estate Remaining Life MortgageLoansOnRealEstateRemainingLife	P1Y7M6D
CY2020Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	1826200000	USD
CY2020Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	1815200000	USD
CY2020	acre	Mortgage Loans On Real Estate Unleveraged Effective Yield MortgageLoansOnRealEstateUnleveragedEffectiveYield	0.063
CY2018Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	1524873000	USD
CY2019	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	493913000	USD
CY2019	acre	Mortgage Loans On Real Estate Receipt Of Origination Fee MortgageLoansOnRealEstateReceiptOfOriginationFee	7539000	USD
CY2019	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	185281000	USD
CY2019	acre	Mortgage Loans On Real Estate Loan Paid Off MortgageLoansOnRealEstateLoanPaidOff	482407000	USD
CY2019	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Transfers To Loans Held For Sale CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldTransfersToLoansHeldForSale	38636000	USD
CY2019	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	7013000	USD
CY2019Q4	acre	Mortgage Loans On Real Estate Total Commitment Amount Including Noncontrolling Interest MortgageLoansOnRealEstateTotalCommitmentAmountIncludingNoncontrollingInterest	1682498000	USD
CY2020	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	430562000	USD
CY2020	acre	Mortgage Loans On Real Estate Receipt Of Origination Fee MortgageLoansOnRealEstateReceiptOfOriginationFee	5778000	USD
CY2020	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	107767000	USD
CY2020	acre	Mortgage Loans On Real Estate Amortizing Payments MortgageLoansOnRealEstateAmortizingPayments	2728000	USD
CY2020	acre	Mortgage Loans On Real Estate Loan Paid Off MortgageLoansOnRealEstateLoanPaidOff	304028000	USD
CY2020	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Transfers To Loans Held For Sale CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldTransfersToLoansHeldForSale	100504000	USD
CY2020	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	7430000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	25200000	USD
CY2020Q4	acre	Mortgage Loanson Real Estate Commitment Reserveor Allowancefor Credit Loss Basis Points MortgageLoansonRealEstateCommitmentReserveorAllowanceforCreditLossBasisPoints	1.25
CY2020Q4	acre	Commitments Commitments	2000000000.0	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	928674000	USD
CY2020Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1249155000	USD
CY2020	acre	Debt Issue Discount On Initial Draw Down DebtIssueDiscountOnInitialDrawDown	2600000	USD
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	894744000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1471424000	USD
CY2020	acre	Line Of Credit Facility Accordion Feature Length Of Extension Period LineOfCreditFacilityAccordionFeatureLengthOfExtensionPeriod	P12M
CY2020	acre	Number Of Non Recourse Notes NumberOfNonRecourseNotes	3	loan
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	277506000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	447092000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	147921000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	56155000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	928674000	USD
CY2020	acre	Number Of Secured Borrowing Arrangements NumberOfSecuredBorrowingArrangements	3	loan
CY2020Q4	acre	Commitments Commitments	2013993000	USD
CY2019Q4	acre	Commitments Commitments	1909084000	USD
CY2020Q4	acre	Funded Commitments FundedCommitments	1826241000	USD
CY2019Q4	acre	Funded Commitments FundedCommitments	1692894000	USD
CY2020Q4	acre	Unfunded Commitments UnfundedCommitments	187752000	USD
CY2019Q4	acre	Unfunded Commitments UnfundedCommitments	216190000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285393	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	263442	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	109346	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	80807	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	358682	shares
CY2020Q4	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestinthe Remainderofthe Year ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestintheRemainderoftheYear	97608	shares
CY2020Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Two ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearTwo	118253	shares
CY2020Q4	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Three ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearThree	89160	shares
CY2020Q4	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Four ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFour	53661	shares
CY2020Q4	acre	Share Based Compensation Arrangementby Share Based Payment Award Equity Instruments Otherthan Options Expectedto Vestin Year Five ShareBasedCompensationArrangementbyShareBasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedtoVestinYearFive	0	shares
CY2020Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants To Date ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsToDate	358682	shares
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3700000	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3100000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2300000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21840000	USD
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	36991000	USD
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	38596000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32977462	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28609282	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28529439	shares
CY2020	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	219046	shares
CY2019	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	237359	shares
CY2018	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	127221	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33196508	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28846641	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28656660	shares
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.66
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.29
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.35
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.66
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.28
CY2018	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.35
CY2020	acre	Excise Taxes Rate ExciseTaxesRate	0.04
CY2020	acre	Related Party Transactions Management Fee Renewal Term RelatedPartyTransactionsManagementFeeRenewalTerm	P1Y
CY2020	acre	Related Party Transactions Termination Fee Based On Average Annual Management And Incentive Fees Ratio RelatedPartyTransactionsTerminationFeeBasedOnAverageAnnualManagementAndIncentiveFeesRatio	3
CY2020	acre	Related Party Transactions Management Fee Look Back Period RelatedPartyTransactionsManagementFeeLookBackPeriod	P24M
CY2020Q4	acre	Number Of Related Party Loans NumberOfRelatedPartyLoans	2	loan
CY2020Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2020Q4	us-gaap	Dividends Dividends	11124000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2020Q3	us-gaap	Dividends Dividends	11072000	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2020Q1	us-gaap	Dividends Dividends	11057000	USD
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2020Q2	us-gaap	Dividends Dividends	11072000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.32
CY2020	us-gaap	Dividends Dividends	44325000	USD
CY2019Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2019Q4	us-gaap	Dividends Dividends	9546000	USD
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2019Q3	us-gaap	Dividends Dividends	9526000	USD
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2019Q2	us-gaap	Dividends Dividends	9527000	USD
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.33
CY2019Q1	us-gaap	Dividends Dividends	9520000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.32
CY2019	us-gaap	Dividends Dividends	38119000	USD
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.31
CY2018Q2	us-gaap	Dividends Dividends	8323000	USD
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2018Q4	us-gaap	Dividends Dividends	8914000	USD
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2018Q2	us-gaap	Dividends Dividends	8036000	USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2018Q1	us-gaap	Dividends Dividends	8008000	USD
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.16
CY2018	us-gaap	Dividends Dividends	33281000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	6400000	USD
CY2020	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	111400000	USD

Files In Submission

Name	View Source	Status
0001628280-21-002412-index-headers.html	Edgar Link	pending
0001628280-21-002412-index.html	Edgar Link	pending
0001628280-21-002412.txt	Edgar Link	pending
0001628280-21-002412-xbrl.zip	Edgar Link	pending
acre-20201231.htm	Edgar Link	pending
acre-20201231.xsd	Edgar Link	pending
acre-20201231_cal.xml	Edgar Link	unprocessable
acre-20201231_def.xml	Edgar Link	unprocessable
acre-20201231_g1.jpg	Edgar Link	pending
acre-20201231_g2.jpg	Edgar Link	pending
acre-20201231_htm.xml	Edgar Link	completed
acre-20201231_lab.xml	Edgar Link	unprocessable
acre-20201231_pre.xml	Edgar Link	unprocessable
acreq4-20exhibit311.htm	Edgar Link	pending
acreq4-20exhibit312.htm	Edgar Link	pending
acreq4-20exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q4-20exhibit211.htm	Edgar Link	pending
q4-20exhibit231.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACRE
Ares Commercial Real Estate Corp Stock $acre

2020 Q4 Form 10-K Financial Statement

#000162828021002412 Filed on February 18, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE Ares Commercial Real Estate Corp Stock $acre

2020 Q4 Form 10-K Financial Statement

#000162828021002412 Filed on February 18, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE
Ares Commercial Real Estate Corp Stock $acre